Informações:
Falhas:
ID
36569
Descrição
Phase II Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN); ODM derived from: https://clinicaltrials.gov/show/NCT01953055
Link
https://clinicaltrials.gov/show/NCT01953055
Palavras-chave
Versões (2)
- 17/01/2019 17/01/2019 -
- 22/05/2019 22/05/2019 -
Titular dos direitos
Sunnybrook Health Sciences Centre
Transferido a
22 de maio de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
SABR in High Risk Prostate Cancer (SATURN) NCT01953055
Eligibility Criteria
- StudyEvent: Eligibility
Similar models
Eligibility Criteria
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
informed consent
Item
informed consent obtained
boolean
C0021430 (UMLS CUI [1])
Age and Gender
Item
men > 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
histologically confirmed prostate adenocarcinoma (centrally reviewed)
Item
histologically confirmed prostate adenocarcinoma (centrally reviewed)
boolean
C0679557 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
C0007112 (UMLS CUI [1,2])
prostate cancer risk assessment, by clinical T stage, Gleason Score, or PSA
Item
high risk prostate cancer, defined as at least one of clinical stage T3 or Gleason 8-10, or PSA > 20ng/ml
boolean
C0600139 (UMLS CUI [1,1])
C0086930 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
C0332326 (UMLS CUI [3])
C0138741 (UMLS CUI [4])
C0086930 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
C0332326 (UMLS CUI [3])
C0138741 (UMLS CUI [4])
prior pelvic radiotherapy
Item
prior pelvic radiotherapy
boolean
C1514463 (UMLS CUI [1,1])
C1536155 (UMLS CUI [1,2])
C1536155 (UMLS CUI [1,2])
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
C0003280 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C4040254 (UMLS CUI [2])
C1548265 (UMLS CUI [1,2])
C4040254 (UMLS CUI [2])
bleeding diathesis
Item
diagnosis of bleeding diathesis
boolean
C0005779 (UMLS CUI [1])
prostate size on imaging at seed insertion
Item
large prostate (>90cm³) on imaging at time of gold seed insertion
boolean
C1287816 (UMLS CUI [1])
C2348792 (UMLS CUI [2,1])
C4040254 (UMLS CUI [2,2])
C2348792 (UMLS CUI [2,1])
C4040254 (UMLS CUI [2,2])
no evidence of castrate resistance (defined by PSA and testosterone)
Item
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l)
boolean
C0332197 (UMLS CUI [1,1])
C4270759 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C0428413 (UMLS CUI [3])
C4270759 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C0428413 (UMLS CUI [3])
definitive regional or distant metastatic disease on staging investigations
Item
definitive regional or distant metastatic disease on staging investigations
boolean
C1275402 (UMLS CUI [1])
C0205147 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
C0205147 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])